ALK-Abello A/S Series B | |
Stock Exchange | Other OTC |
EPS |
$1.5 |
Market Cap |
$2.41 B |
Shares Outstanding |
9.21 M |
Public Float |
- |
ALK-Abello A/S Series B | |
Stock Exchange | Copenhagen Stock Exchange |
EPS |
DKK9.64 |
Market Cap |
DKK16.84 B |
Shares Outstanding |
10.13 M |
Public Float |
6.44 M |
Address |
Bøge Allé 6-8 Hørsholm CR 2970 Denmark |
Employees | - |
Website | http://www.alk.net |
Updated | 07/08/2019 |
ALK-Abello A/S engages in the production and development of pharmaceutical products to prevent and treat allergies. It also manufactures tablet-based allergy vaccines for pollen, house dust mites, animals, and insect stings. Its treatment comprises allergy vaccines, emergency treatment, and allergy diagnostics. |